Physician profile
Patrick J Mcintyre
NPI 1831142140
$14,643.44
in general payments reported to CMS, 2019-2025
23 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.48 · 2021: $7,120 · 2022: $1,591 · 2023: $1,953 · 2024: $3,208 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,354 · Travel and Lodging: $1,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,354.48 |
| Travel and Lodging | $1,561.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,213.03 | 2020-2025 | Intracept, General - Pain Management, Spectra Wavewriter |
| Medtronic, INC. | $1,601.91 | 2022-2024 | Synchromedii |
| Abbott Laboratories | $1,371.88 | 2022-2024 | Eterna, Proclaim |
| Relievant Medsystems, INC. | $1,311.68 | 2021-2023 | Intracept |
| Nevro Corp. | $610.76 | 2021-2024 | Senza |
| Mml US, INC. | $366.52 | 2023-2025 | Reactiv8 |
| Spr Therapeutics, INC | $237.18 | 2022-2025 | Sprint Pns System |
| Nalu Medical, INC. | $188.89 | 2021-2023 | Nalu Neurostimulation System |
| Stryker Corporation | $168.73 | 2021-2023 | Spinejack, Multigen 2 |
| Spinal Simplicity, LLC | $114.83 | 2022-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $77.68 | 2023-2024 | Mild Device Kit |
| Globus Medical, INC. | $55.03 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $50.64 | 2024-2025 | |
| Stimwave Technologies Incorporated | $42.69 | 2021-2022 | |
| Abbvie INC. | $41.86 | 2023-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $36.47 | 2025 | Prospera |
| Averitas Pharma INC. | $27.86 | 2024 | Qutenza |
| Tersera Therapeutics LLC | $27.00 | 2025 | Prialt |
| Axonics, INC. | $25.13 | 2021 | |
| Curonix LLC | $24.77 | 2022-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $17.50 | 2023 | Painteq |
| Bioventus LLC | $17.40 | 2021 | |
| Novo Nordisk INC | $14.00 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.